Clinical trial

Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue…

NCT00023725 · Radiation Therapy Oncology Group, Other · Completed

Key facts

NCT number NCT00023725
Title Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma
Official title A Randomized Phase I/II Study Of Preoperative Radiotherapy With/Without SUGEN 5416 (NSC # 696819; A TK Inhibitor Anti-Angiogenesis Compound) In The Management Of Low To Intermediate Grade Soft Tissue Sarcoma Of The Trunk or Extremity
Lead sponsor Radiation Therapy Oncology Group, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Sarcoma
Intervention type Drug, Procedure, Radiation
Interventions semaxanib, conventional surgery, radiation therapy
Start date Aug 1, 2001
Completion Oct 1, 2003
First posted Oct 15, 2003
Last update posted Jun 24, 2013
Countries Canada, United States

At a glance

  • 100–999 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies